Regeneron Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

• Fourth quarter 2025 revenues increased 3% to $3.9 billion versus fourth quarter 2024; full year 2025 revenues increased 1% to $14.3 billion versus 2024
• Fourth quarter 2025 Dupixent® g… [+76226 chars]

पूरा लेख पढ़ें →